Germany Joins France In Suspending Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos; Japan Does Not Plan to Recall Drug  
6/10/2011 8:07:56 AM

(Reuters) - Germany has joined France in suspending the use of Takeda Pharmaceutical's Actos diabetes drug, due to worries about a possible link to cancer. The move is a blow for the Japanese firm, whose best-selling drug has worldwide sales of close to $5 billion, though the financial impact will be limited by the fact the drug faces looming generic competition in key markets.